Johnson & Johnson in discussion with FDA regarding COVID-19 vaccine side effects
Johnson & Johnson said on Monday it was in discussions with the US Food and Drug Administration about rare cases of a neurological disorder, Guillain-Barré syndrome, that have been reported following vaccination with the Janssen COVID-19 vaccine.
The chance of having Guillain-Barré syndrome occur is very low and the rate of reported cases exceeds the background rate by a small degree, J&J said.
Subscribe
Please login to comment
0 Comments
RELATED NEWS
